Shanghai Opm Biosciences Stock Fundamentals
| 688293 Stock | 42.98 0.20 0.47% |
Shanghai OPM Biosciences fundamentals help investors to digest information that contributes to Shanghai OPM's financial success or failures. It also enables traders to predict the movement of Shanghai Stock. The fundamental analysis module provides a way to measure Shanghai OPM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shanghai OPM stock.
At present, Shanghai OPM's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 4.2 M, whereas Interest Income is forecasted to decline to about 12.1 M. Shanghai | Select Account or Indicator |
Shanghai OPM Biosciences Company Current Valuation Analysis
Shanghai OPM's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Shanghai OPM Current Valuation | 3.7 B |
Most of Shanghai OPM's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shanghai OPM Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Shanghai OPM Biosciences has a Current Valuation of 3.7 B. This is 74.21% lower than that of the Biotechnology sector and 20.27% lower than that of the Health Care industry. The current valuation for all China stocks is 77.72% higher than that of the company.
Shanghai OPM Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shanghai OPM's current stock value. Our valuation model uses many indicators to compare Shanghai OPM value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shanghai OPM competition to find correlations between indicators driving Shanghai OPM's intrinsic value. More Info.Shanghai OPM Biosciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.20 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Shanghai OPM Biosciences is roughly 5.00 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Shanghai OPM by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shanghai OPM's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Shanghai Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shanghai OPM's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Shanghai OPM could also be used in its relative valuation, which is a method of valuing Shanghai OPM by comparing valuation metrics of similar companies.Shanghai OPM is currently under evaluation in current valuation category among its peers.
Shanghai Fundamentals
| Return On Equity | 0.0175 | ||||
| Return On Asset | 0.0035 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 3.7 B | ||||
| Shares Outstanding | 114.77 M | ||||
| Shares Owned By Insiders | 36.34 % | ||||
| Shares Owned By Institutions | 43.11 % | ||||
| Price To Book | 2.34 X | ||||
| Price To Sales | 16.61 X | ||||
| Revenue | 243.12 M | ||||
| Gross Profit | 294.37 M | ||||
| EBITDA | 43.59 M | ||||
| Net Income | 54.04 M | ||||
| Total Debt | 8.6 M | ||||
| Book Value Per Share | 19.01 X | ||||
| Cash Flow From Operations | 57.95 M | ||||
| Earnings Per Share | 0.33 X | ||||
| Target Price | 53.41 | ||||
| Number Of Employees | 285 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 4.91 B | ||||
| Total Asset | 2.3 B | ||||
| Retained Earnings | 131.52 M | ||||
| Working Capital | 1.59 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 2.3 B | ||||
| Last Dividend Paid | 0.45 |
About Shanghai OPM Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shanghai OPM Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai OPM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai OPM Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 243.1 M | 240.7 M | |
| Cost Of Revenue | 100.1 M | 98.7 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai OPM financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai OPM security.